Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY192019-06-30 | Q1 FY192019-03-31 | Q4 FY182018-12-31 | Q3 FY182018-09-30 | Q2 FY182018-06-30 | Q1 FY182018-03-31 | Q4 FY172017-12-31 | Q3 FY172017-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $157.00K | — | $1.48M | $40.79M | $9.04M | $8.20M | $4.27M | $27.19M |
| Gross profit | $157.00K | — | $1.48M | $40.79M | $9.04M | $8.20M | $4.27M | $27.19M |
| Gross margin | 100.0% | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | $25.51M | $22.02M | $22.77M | $23.48M | $26.62M | $25.73M | $25.15M | $24.03M |
| Selling, general and administrative | $10.15M | $11.77M | $10.82M | $10.29M | $11.29M | $11.20M | $8.82M | $8.11M |
| Operating expenses | $35.66M | $33.79M | $33.59M | $33.77M | $37.92M | $36.94M | $33.97M | $32.15M |
| Operating income | −$35.50M | −$33.79M | −$32.11M | $7.02M | −$28.88M | −$28.74M | −$29.70M | −$4.96M |
| Operating margin | -22612.7% | — | -2170.8% | 17.2% | -319.5% | -350.7% | -695.6% | -18.2% |
| EBITDA | −$33.52M | −$31.80M | −$32.11M | $8.93M | −$26.96M | −$26.86M | −$27.96M | −$3.46M |
| Interest income | $757.00K | $952.00K | $1.04M | $606.00K | $540.00K | $659.00K | $765.00K | $705.00K |
| Income before taxes | −$41.02M | −$27.41M | −$36.04M | $5.38M | −$43.74M | −$20.95M | −$27.43M | −$653.00K |
| Income taxes | $65.00K | $2.00K | $135.00K | $133.00K | $102.00K | $127.00K | −$170.00K | $225.00K |
| Net income | −$41.09M | −$27.41M | −$36.17M | $5.24M | −$43.85M | −$21.08M | −$27.26M | −$878.00K |
| Net margin | -26170.1% | — | -2445.8% | 12.9% | -485.1% | -257.2% | -638.5% | -3.2% |
| EPS, basic | −$0.07 | −$0.04 | −$0.06 | $0.01 | −$0.08 | −$0.04 | −$0.05 | — |
| EPS, diluted | −$0.07 | −$0.04 | −$0.06 | $0.01 | −$0.08 | −$0.04 | −$0.05 | — |
| Diluted shares | 629.36M | 627.95M | 584.34M | 621.76M | 565.20M | 562.38M | 527.64M | 561.24M |
Figures describe Ascendis Pharma A/S shares, not any token. As of Feb 25, 2021, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.